$3.05
9.22% today
Nasdaq, Apr 04, 08:46 pm CET
ISIN
US09075F1075
Symbol
BNGO
Sector
Industry

BioNano Genomics, Inc. Stock price

$3.36
-0.64 16.00% 1M
-22.98 87.24% 6M
-13.94 80.58% YTD
-57.84 94.51% 1Y
-1,634.64 99.79% 3Y
-161.64 97.96% 5Y
-4,190.64 99.92% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.39 10.40%
ISIN
US09075F1075
Symbol
BNGO
Sector
Industry

Key metrics

Market capitalization $10.10m
Enterprise Value $16.92m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.55
P/S ratio (TTM) P/S ratio 0.33
P/B ratio (TTM) P/B ratio 0.18
Revenue growth (TTM) Revenue growth -14.79%
Revenue (TTM) Revenue $30.78m
EBIT (operating result TTM) EBIT $-86.31m
Free Cash Flow (TTM) Free Cash Flow $-70.77m
Cash position $20.48m
EPS (TTM) EPS $-91.86
P/E forward negative
P/S forward 0.33
EV/Sales forward 0.55
Short interest 18.60%
Show more

Is BioNano Genomics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

BioNano Genomics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a BioNano Genomics, Inc. forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a BioNano Genomics, Inc. forecast:

Hold
100%

Financial data from BioNano Genomics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
31 31
15% 15%
100%
- Direct Costs 30 30
15% 15%
99%
0.38 0.38
96% 96%
1%
- Selling and Administrative Expenses 48 48
34% 34%
155%
- Research and Development Expense 25 25
54% 54%
81%
-72 -72
38% 38%
-234%
- Depreciation and Amortization 14 14
4% 4%
46%
EBIT (Operating Income) EBIT -86 -86
34% 34%
-280%
Net Profit -112 -112
52% 52%
-364%

In millions USD.

Don't miss a Thing! We will send you all news about BioNano Genomics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioNano Genomics, Inc. Stock News

Neutral
Seeking Alpha
4 days ago
Bionano Genomics, Inc. (NASDAQ:BNGO ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants David Holmes - IR Erik Holmlin - CEO and Principal Financial Officer Conference Call Participants Sung Ji Nam - Scotiabank Operator Good day, and welcome to the Bionano Fourth Quarter 2024 Earnings Conference Call. Today's conference is being recorded.
Neutral
GlobeNewsWire
4 days ago
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook for 2025. “2024 has been an important year for Bionano.
Neutral
GlobeNewsWire
11 days ago
SAN DIEGO, and GREENWOOD, S.C., March 24, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) and Greenwood Genetic Center (GGC) today announced a publication in Genome Research describing the first study to use optical genome mapping (OGM) to investigate the genetic landscape of neural tube defects (NTDs). NTDs are the most common birth defect of the central nervous system and some ...
More BioNano Genomics, Inc. News

Company Profile

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Head office United States
CEO Robert Holmlin
Employees 100
Founded 2003
Website www.bionano.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today